Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Time to Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped down prior to trading on Thursday . The stock had previously closed at $9.70, but opened at $9.32. Curaleaf shares last traded at $9.6313, with a volume of 5,990 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Zacks Research cut shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy”.

Curaleaf Stock Down 0.8%

The business has a 50-day simple moving average of $7.63 and a 200-day simple moving average of $7.51. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.74 and a current ratio of 1.56. The company has a market cap of $2.24 billion, a price-to-earnings ratio of -24.67 and a beta of 1.51.

Curaleaf (OTCMKTS:CURLF) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.51. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The business had revenue of $324.23 million during the quarter, compared to the consensus estimate of $316.62 million. On average, equities analysts anticipate that Curaleaf Holdings, Inc. will post -0.31 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.